Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis. 2012

Mohammed Mullazehi, and Marius C Wick, and Lars Klareskog, and Ronald van Vollenhoven, and Johan Rönnelid
Clinical Immunology, Department of Immunology, Genetics and Pathology, Rudbeck Laboratory C5, Uppsala University, Uppsala, SE-75185, Sweden.

BACKGROUND We have previously reported that high levels of antibodies specific for native human type II collagen (anti-CII) at the time of RA diagnosis were associated with concurrent but not later signs of inflammation. This was associated with CII/anti-CII immune complex (IC)-induced production of pro-inflammatory cytokines in vitro. In contrast, anti-cyclic citrullinated peptide antibodies (anti-CCP) were associated both with late inflammation and late radiological destruction in the same RA cohort. We therefore hypothesized that anti-CII are also associated with early erosions. METHODS Two-hundred-and-fifty-six patients from an early RA cohort were included. Baseline levels of anti-CII, anti-CCP and anti-mutated citrullinated vimentin were analyzed with ELISA, and rheumatoid factor levels were determined by nephelometry. Radiographs of hands and feet at baseline, after one and after two years were quantified using the 32-joints Larsen erosion score. RESULTS Levels of anti-CII were bimodally distributed in the RA cohort, with a small (3.1%, 8/256) group of very high outliers with a median level 87 times higher than the median for the healthy control group. Using a cut-off discriminating the outlier group that was associated with anti-CII IC-induced production of proinflammatory cytokines in vitro, baseline anti-CII antibodies were significantly (p = 0.0486) associated with increased radiographic damage at the time of diagnosis. Anti-CII-positive patient had also significantly increased HAQ score (p = 0.0303), CRP (p = 0.0026) and ESR (p = 0.0396) at the time of diagnosis but not during follow-up. The median age among anti-CII-positive subjects was 12 years higher than among the anti-CII-negative patients. CONCLUSIONS In contrary to anti-CCP, anti-CII-positive patients with RA have increased joint destruction and HAQ score at baseline. Anti-CII thus characterizes an early inflammatory/destructive phenotype, in contrast to the late appearance of an inflammatory/destructive phenotype in anti-CCP positive RA patients. The anti-CII phenotype might account for part of the elderly acute onset RA phenotype with rather good prognosis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011859 Radiography Examination of any part of the body for diagnostic purposes by means of X-RAYS or GAMMA RAYS, recording the image on a sensitized surface (such as photographic film). Radiology, Diagnostic X-Ray,Roentgenography,X-Ray, Diagnostic,Diagnostic X-Ray,Diagnostic X-Ray Radiology,X-Ray Radiology, Diagnostic,Diagnostic X Ray,Diagnostic X Ray Radiology,Diagnostic X-Rays,Radiology, Diagnostic X Ray,X Ray Radiology, Diagnostic,X Ray, Diagnostic,X-Rays, Diagnostic
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D024043 Collagen Type II A fibrillar collagen found predominantly in CARTILAGE and vitreous humor. It consists of three identical alpha1(II) chains. Collagen Type II, alpha1 Chain,Collagen Type II, alpha1 Subunit,Collagen alpha1(II),Procollagen Type II,Type II Collagen,Type II Procollagen,Collagen, Type II,Procollagen, Type II

Related Publications

Mohammed Mullazehi, and Marius C Wick, and Lars Klareskog, and Ronald van Vollenhoven, and Johan Rönnelid
February 1993, Ryumachi. [Rheumatism],
Mohammed Mullazehi, and Marius C Wick, and Lars Klareskog, and Ronald van Vollenhoven, and Johan Rönnelid
April 1993, British journal of rheumatology,
Mohammed Mullazehi, and Marius C Wick, and Lars Klareskog, and Ronald van Vollenhoven, and Johan Rönnelid
July 1994, The Journal of rheumatology,
Mohammed Mullazehi, and Marius C Wick, and Lars Klareskog, and Ronald van Vollenhoven, and Johan Rönnelid
October 1996, Arthritis and rheumatism,
Mohammed Mullazehi, and Marius C Wick, and Lars Klareskog, and Ronald van Vollenhoven, and Johan Rönnelid
January 2005, Nihon rinsho. Japanese journal of clinical medicine,
Mohammed Mullazehi, and Marius C Wick, and Lars Klareskog, and Ronald van Vollenhoven, and Johan Rönnelid
April 1996, Zhonghua nei ke za zhi,
Mohammed Mullazehi, and Marius C Wick, and Lars Klareskog, and Ronald van Vollenhoven, and Johan Rönnelid
May 1984, Tissue antigens,
Mohammed Mullazehi, and Marius C Wick, and Lars Klareskog, and Ronald van Vollenhoven, and Johan Rönnelid
October 1990, Arthritis and rheumatism,
Mohammed Mullazehi, and Marius C Wick, and Lars Klareskog, and Ronald van Vollenhoven, and Johan Rönnelid
March 2011, Joint bone spine,
Mohammed Mullazehi, and Marius C Wick, and Lars Klareskog, and Ronald van Vollenhoven, and Johan Rönnelid
December 1990, Journal of autoimmunity,
Copied contents to your clipboard!